These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19808298)

  • 1. Metabolic syndrome, inflammation, and incident heart failure in the elderly: the cardiovascular health study.
    Suzuki T; Katz R; Jenny NS; Zakai NA; LeWinter MM; Barzilay JI; Cushman M
    Circ Heart Fail; 2008 Nov; 1(4):242-8. PubMed ID: 19808298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (Multi-Ethnic Study of Atherosclerosis) study.
    Bahrami H; Bluemke DA; Kronmal R; Bertoni AG; Lloyd-Jones DM; Shahar E; Szklo M; Lima JA
    J Am Coll Cardiol; 2008 May; 51(18):1775-83. PubMed ID: 18452784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipoprotein-associated phospholipase A(2) and risk of congestive heart failure in older adults: the Cardiovascular Health Study.
    Suzuki T; Solomon C; Jenny NS; Tracy R; Nelson JJ; Psaty BM; Furberg C; Cushman M
    Circ Heart Fail; 2009 Sep; 2(5):429-36. PubMed ID: 19808373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome predicts incident congestive heart failure: a 20-year follow-up study of elderly Finns.
    Wang J; Sarnola K; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Atherosclerosis; 2010 May; 210(1):237-42. PubMed ID: 19945701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.
    Vasan RS; Sullivan LM; Roubenoff R; Dinarello CA; Harris T; Benjamin EJ; Sawyer DB; Levy D; Wilson PW; D'Agostino RB;
    Circulation; 2003 Mar; 107(11):1486-91. PubMed ID: 12654604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome, C-reactive protein, and mortality in U.S. Blacks and Whites: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study.
    Suzuki T; Voeks J; Zakai NA; Jenny NS; Brown TM; Safford MM; LeWinter M; Howard G; Cushman M
    Diabetes Care; 2014 Aug; 37(8):2284-90. PubMed ID: 24879838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between metabolic syndrome, C-reactive protein, and the risk of primary liver cancer: a large prospective study.
    Song M; Liu T; Liu H; Zhang Q; Zhang Q; Wang Y; Ma X; Cao L; Shi H
    BMC Cancer; 2022 Aug; 22(1):853. PubMed ID: 35927639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome, inflammation, and risk of symptomatic peripheral artery disease in women: a prospective study.
    Conen D; Rexrode KM; Creager MA; Ridker PM; Pradhan AD
    Circulation; 2009 Sep; 120(12):1041-7. PubMed ID: 19738135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study.
    Barac A; Wang H; Shara NM; de Simone G; Carter EA; Umans JG; Best LG; Yeh J; Dixon DB; Devereux RB; Howard BV; Panza JA
    J Clin Hypertens (Greenwich); 2012 Jan; 14(1):13-9. PubMed ID: 22235819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study.
    Hussein AA; Gottdiener JS; Bartz TM; Sotoodehnia N; DeFilippi C; See V; Deo R; Siscovick D; Stein PK; Lloyd-Jones D
    Heart Rhythm; 2013 Oct; 10(10):1425-32. PubMed ID: 23906927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study.
    Kalogeropoulos A; Georgiopoulou V; Psaty BM; Rodondi N; Smith AL; Harrison DG; Liu Y; Hoffmann U; Bauer DC; Newman AB; Kritchevsky SB; Harris TB; Butler J;
    J Am Coll Cardiol; 2010 May; 55(19):2129-37. PubMed ID: 20447537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between HDL particle concentration and incident metabolic syndrome in the multi-ethnic Dallas Heart Study.
    Mani P; Ren HY; Neeland IJ; McGuire DK; Ayers CR; Khera A; Rohatgi A
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1(Suppl 1):S175-S179. PubMed ID: 27993539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study.
    Cesari M; Penninx BW; Newman AB; Kritchevsky SB; Nicklas BJ; Sutton-Tyrrell K; Rubin SM; Ding J; Simonsick EM; Harris TB; Pahor M
    Circulation; 2003 Nov; 108(19):2317-22. PubMed ID: 14568895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic syndrome and risk of incident peripheral artery disease: the cardiovascular health study.
    Garg PK; Biggs ML; Carnethon M; Ix JH; Criqui MH; Britton KA; Djoussé L; Sutton-Tyrrell K; Newman AB; Cushman M; Mukamal KJ
    Hypertension; 2014 Feb; 63(2):413-9. PubMed ID: 24191289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men.
    Matsushita K; Yatsuya H; Tamakoshi K; Wada K; Otsuka R; Takefuji S; Sugiura K; Kondo T; Murohara T; Toyoshima H
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):871-6. PubMed ID: 16456090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study.
    Pokharel Y; Sun W; Villareal DT; Selvin E; Virani SS; Ndumele CE; Hoogeveen RC; Coresh J; Boerwinkle E; Butler KR; Solomon SD; Pankow JS; Bozkurt B; Ballantyne CM; Nambi V
    Eur J Prev Cardiol; 2017 Apr; 24(6):628-638. PubMed ID: 27941157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle Mass and Inflammation in Older Adults: Impact of the Metabolic Syndrome.
    Buchmann N; Fielitz J; Spira D; König M; Norman K; Pawelec G; Goldeck D; Demuth I; Steinhagen-Thiessen E
    Gerontology; 2022; 68(9):989-998. PubMed ID: 35100595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between Low-Grade Inflammation and Hyperuricemia in Adults With Metabolic Syndrome in Yucatán, México.
    Banik SD; Avila-Nava A; Lugo R; Chim Aké R; Gutiérrez Solis AL
    Can J Diabetes; 2022 Jun; 46(4):369-374. PubMed ID: 35484052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and 10-year cardiovascular disease incidence: The ATTICA study.
    Kastorini CM; Panagiotakos DB; Georgousopoulou EN; Laskaris A; Skourlis N; Zana A; Chatzinikolaou C; Chrysohoou C; Puddu PE; Tousoulis D; Stefanadis C; Pitsavos C;
    Nutr Metab Cardiovasc Dis; 2016 Mar; 26(3):223-31. PubMed ID: 26803591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.